BCG Biosensor and Non- and Invasive Monitoring During Emergency Medicine Cases, a Prospective Feasibility Study
Key facts
- Who runs it
- Oslo University Hospital
- Where
- Norway1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 183 people enrolled
- Started
- 18 May 2021
- Ended
- 3 Jan 2024
- Type of study
- Interventional, 4 groups
- Treatments tested
- LUCAS 2 Active Decompression 2
- Hypotension
- Intensive care transport
- Record updated
- 3 April 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Non-traumatic cardiac arrest, hypotension, intensive care transport where an attempt of resuscitation and treatment is considered appropriate in patients age ≥18 years
Who cannot take part
- Age <18 years; Traumatic cardiac arrest; Known pregnancy (can be included in the hypotension group); Victim not to be resuscitated (DNR orders); Internals in prison; Included once in the study already; Patients too small for LUCAS 2-AD2 < 18.5 cm chest height; Patient too big for LUCAS 2-AD2 > 27.3 cm chest height; Chest or upper abdomen surgery (Large scars on the chest, only in the CPR group; Sustained Restoration Of Spontaneous Circulation (ROSC) occurring before the LUCAS 2-AD2 can be applied to the patient, such that further CPR is not needed
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In a out of hospital emergency medicine study the investigators will measure hemodynamic effects of implemented treatments for patients with cardiac arrest, hypotension, and intensive care transports. The investigators will use both non-invasive and invasive measuring technology to measure this. Ballistocardiographic biosensors are introduced together with more advanced non-invasive and invasive measurements such as invasive arterial blood pressure with cardiac output calculation and saturation cerebral tissue oxygenation (SctO2). During treatment of cardiac arrest patients the investigators will use a new LUCAS 2 Active Decompression device (LUCAS 2 AD2) and measure different hemodynamic variables.
The 4 groups in the trial
- Cardiac arrest patientsOther group
Cardiac arrest patients receiving cardiopulmonary resuscitation with LUCAS 2 Active Decompression 2.
Treatment: LUCAS 2 Active Decompression 2
- HypotensionOther group
Patients developed or may develope hypotension of non traumatic origin.
- Intensive care patient transportOther group
Patients who are transported from one intensive department to another.
Treatment: Intensive care transport
- LUCAS 2 Active DecompressionOther group
The hemodynamic measurements of the cardiac arrest patients in the present study will be compared with the hemodynamic measurements achieved in the previous study NCT02479152.
Treatment: LUCAS 2 Active Decompression 2
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prehospital Use of a Ballistocardiographic Biosensor to Non-invasively and Invasive Pulse Contour Analysis to Monitor Hemodynamics and Blood Flow During Emergency Medicine Cases, a Prehospital Prospective Feasibility Study
- Record updated
- 3 April 2024